Prescribing Information - Wegovy
GLP-1s for Osteoarthritis GLP-1 drugs may slow the progression of osteoarthritis, as research has found that people on the drugs lost more weight and had fewer knee surgeries than people not taking a GLP-1
I confirm that I am over 18 years of age, have read and understood the Research Use Only Disclaimer, and acknowledge that all products are purchased solely for lawful research purposes and are not intended for human or animal consumption
The highest risk was in semaglutide (HR=1.39), then liraglutide (HR=1.25)
protect from light and moisture Contraindications & Handling Warnings For licensed research institutions and professionals only Do not inject or consume under any circumstances Avoid contact with skin, eyes, or mucous membranes Use appropriate PPE (personal protective equipment) when handling Dispose of unused material in compliance with local regulations Quality Assurance Produced in a cGMP-compliant facility in the USA Subjected to independent laboratory testing for identity, potency, and purity Certificate of Analysis (CoA) available upon request for research verification FDA Disclaimer This product is not approved by the United States Food and Drug Administration (FDA)
For patients comparing costs between medications, the semaglutide to tirzepatide dosage comparison helps clarify how dose equivalencies affect total monthly spend